Research Australia recently provided a submission to IP Australia’s consultation on streamlining and simplifying IP regulation.
As the national peak body for the health and medical research and innovation sector, Research Australia has consistently highlighted the need for clearer and more streamlined IP policy and supports to strengthen Australia’s commercialisation pipeline and sovereign capability development. This has been reflected in our recent policy submissions to the Strategic Examination of R&D (SERD) and draft National Health and Medical Research Strategy – where we advocated for measures to help researchers and businesses navigate and protect IP rights. These recommendations formed part of a broader range of measures to overcome the current ‘valley of death’ between discovery and real-world translation, commercialisation and innovation.
You can read our full submission here.
